Atria Investments Inc Sells 491 Shares of Agilent Technologies, Inc. $A

by · The Cerbat Gem

Atria Investments Inc decreased its position in Agilent Technologies, Inc. (NYSE:A – Free Report) by 6.8% during the 2nd quarter, Holdings Channel reports. The firm owned 6,740 shares of the medical research company’s stock after selling 491 shares during the period. Atria Investments Inc’s holdings in Agilent Technologies were worth $795,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Generation Investment Management LLP grew its holdings in shares of Agilent Technologies by 19.8% during the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock worth $582,976,000 after acquiring an additional 824,243 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Agilent Technologies by 18.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after purchasing an additional 604,124 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Agilent Technologies by 141.5% during the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock valued at $109,481,000 after purchasing an additional 548,344 shares during the period. Woodline Partners LP increased its stake in shares of Agilent Technologies by 681.6% in the 1st quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock worth $61,072,000 after purchasing an additional 455,276 shares in the last quarter. Finally, Nordea Investment Management AB raised its stake in Agilent Technologies by 16.2% during the 2nd quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock worth $383,143,000 after acquiring an additional 447,207 shares during the period. 87.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on A. JPMorgan Chase & Co. upped their target price on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target for the company. Wells Fargo & Company upped their price target on Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. Finally, UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and upped their target price for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $149.62.

View Our Latest Stock Report on Agilent Technologies

Agilent Technologies Price Performance

Agilent Technologies stock opened at $146.69 on Friday. The stock has a market capitalization of $41.59 billion, a P/E ratio of 34.43, a P/E/G ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The company’s fifty day moving average price is $135.48 and its 200 day moving average price is $122.30. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the previous year, the firm posted $1.32 EPS. Agilent Technologies’s revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).